PLN 3.1
(-2.82%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -537.61 Thousand PLN | 76.94% |
2022 | -2.33 Million PLN | 37.22% |
2021 | -3.71 Million PLN | 62.99% |
2020 | -10.03 Million PLN | -689.44% |
2019 | -1.27 Million PLN | 71.93% |
2018 | -4.52 Million PLN | 17.75% |
2017 | -5.5 Million PLN | 40.84% |
2016 | -9.3 Million PLN | -133.69% |
2015 | -3.98 Million PLN | -537.83% |
2014 | 909.59 Thousand PLN | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -2.26 Million PLN | -109.82% |
2024 Q1 | -1.07 Million PLN | -100.7% |
2023 Q2 | -1.81 Million PLN | 50.75% |
2023 Q4 | -537.61 Thousand PLN | 47.34% |
2023 Q1 | -3.68 Million PLN | -58.21% |
2023 Q3 | -1.02 Million PLN | 43.81% |
2023 FY | -537.61 Thousand PLN | 76.94% |
2022 Q1 | -2.1 Million PLN | 43.39% |
2022 FY | -2.33 Million PLN | 37.22% |
2022 Q4 | -2.33 Million PLN | -313.05% |
2022 Q3 | -564.52 Thousand PLN | 68.47% |
2022 Q2 | -1.79 Million PLN | 14.86% |
2021 Q3 | -5.66 Million PLN | 17.94% |
2021 Q2 | -6.89 Million PLN | 17.36% |
2021 Q1 | -8.34 Million PLN | 16.82% |
2021 FY | -3.71 Million PLN | 62.99% |
2021 Q4 | -3.71 Million PLN | 34.38% |
2020 Q1 | -1.5 Million PLN | -18.75% |
2020 Q4 | -10.03 Million PLN | -2942.6% |
2020 Q3 | -329.81 Thousand PLN | -296.61% |
2020 FY | -10.03 Million PLN | -689.44% |
2020 Q2 | 167.75 Thousand PLN | 111.11% |
2019 Q3 | -2.5 Million PLN | 5.29% |
2019 Q1 | -3.9 Million PLN | 13.8% |
2019 FY | -1.27 Million PLN | 71.93% |
2019 Q4 | -1.27 Million PLN | 49.17% |
2019 Q2 | -2.64 Million PLN | 32.36% |
2018 Q1 | -4.39 Million PLN | 21.15% |
2018 Q4 | -4.52 Million PLN | -387.86% |
2018 Q2 | -1.1 Million PLN | 74.85% |
2018 Q3 | -928.18 Thousand PLN | 16.04% |
2018 FY | -4.52 Million PLN | 17.75% |
2017 Q4 | -5.57 Million PLN | -224.43% |
2017 Q1 | 9.3 Million PLN | 0.0% |
2017 FY | -5.5 Million PLN | 40.84% |
2017 Q3 | -1.71 Million PLN | 0.0% |
2016 FY | -9.3 Million PLN | -133.69% |
2015 FY | -3.98 Million PLN | -537.83% |
2014 FY | 909.59 Thousand PLN | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Bioceltix S.A. | -9.13 Million PLN | 94.115% |
BIOTON S.A. | 64.81 Million PLN | 100.83% |
Captor Therapeutics Spolka Akcyjna | -71.92 Million PLN | 99.253% |
Mabion S.A. | -11.98 Million PLN | 95.516% |
Molecure S.A. | -56.84 Million PLN | 99.054% |
Pharmena S.A. | -22.05 Million PLN | 97.563% |
Poltreg S.A. | -57.75 Million PLN | 99.069% |
Pure Biologics Spólka Akcyjna | 9.33 Million PLN | 105.761% |
Ryvu Therapeutics S.A. | -57.03 Million PLN | 99.057% |
Synthaverse S.A. | 67.86 Million PLN | 100.792% |
Urteste S.A. | -512 Thousand PLN | -5.002% |